Open AccessMolecular Biomarkers for Spinal Muscular Atrophy
Author(s) -
Angela NavarreteOpazo,
Sheldon R Garrison,
Mindy R. Waite
Publication year - 2021
Publication title -
neurology. clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.674
H-Index - 29
eISSN - 2163-0933
pISSN - 2163-0402
DOI - 10.1212/cpj.0000000000000872
Subject(s) - sma* , spinal muscular atrophy , medicine , biomarker , disease , oncology , medline , psycinfo , bioinformatics , physical medicine and rehabilitation , biology , biochemistry , mathematics , combinatorics
There is an unmet need for reliable biomarkers to predict disease severity, prognosis, and treatment effect in patients with spinal muscular atrophy (SMA). The purpose of this review is to evaluate the clinical utility of blood-based biomarkers in patients with SMA.